Intelligence / Healthtech / New Clinical Trials
ClinicalLIVEUpdated 18 Nov 2026
New Clinical Trials
Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.
Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.
Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777 Growth
By month
777
Signals
What the register says this week, and why it matters if you sell into it.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
- 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
- A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
PostedSponsorStudyPhaseStatus
23 Oct 2026Keymed Biosciences Co.LtdChinaStudy of CM529D1 in Participants With Advanced Solid TumorsPhase 1, Phase 2Not Yet Recruiting23 Oct 2026Sunshine Lake Pharma Co., Ltd.ChinaHEC53856 Tablets for Chemotherapy-induced Anemia in Non-myeloid MalignanciesPhase 2Not Yet Recruiting22 Oct 2026AstraZenecaChinaObservational Study of the Real-world Effectiveness and Safety of Selumetinib Treating Adult Patients With Neurofibromatosis Type 1 (NF1) Who Have Symptomatic, Inoperable Plexiform Neurofibroma (PN)Recruiting22 Oct 2026Beijing Keymed Biosciences Co., Ltd.ChinaStudy of CM512 Injection in Patients With Perennial Allergic Rhinitis on Background TherapyPhase 2Not Yet Recruiting22 Oct 2026Beijing Suncadia Pharmaceuticals Co., LtdChinaA Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SHR 3201 Injection in Healthy ParticipantsPhase 1Not Yet Recruiting22 Oct 2026ChinaNormChinaB5 Serum 4-week Clinical StudyNot applicableCompleted22 Oct 2026Dizal PharmaceuticalsChinaAssessing the Effect of a Proton Pump Inhibitor on the Pharmacokinetics of DZD8586 in Healthy Participants (TAI-SHAN21)Phase 1Recruiting22 Oct 2026Fosun Pharmaceutical Industrial Development (Shenzhen) Co., Ltd.ChinaA Phase II Study of FXR0906 in Patients With Severe Hypertriglyceridemia or Hypertriglyceridemia With ASCVD.Phase 2Not Yet Recruiting22 Oct 2026Jiangsu Guiqiong Pharmaceutical Co., Ltd.ChinaA Phase II Clinical Study Evaluating the Efficacy and Safety of SXRN Injection in Patients With Cancer CachexiaPhase 2Not Yet Recruiting22 Oct 2026Sinovac Biotech Co., LtdChinaPhase I Clinical Trial of Trivalent Inactivated Split Influenza Virus Vaccine (MDCK Cell)Phase 1Not Yet Recruiting22 Oct 2026Sinovac Biotech Co., LtdChinaStudy on the Long-Term Persistence of Immunity Induced by Inactivated Hepatitis A VaccineRecruiting22 Oct 2026SPH Sine Pharmaceutical Laboratories Co., Ltd.ChinaWST03 Capsule Combined With Metronidazole for Bacterial VaginosisPhase 2Not Yet Recruiting21 Oct 2026Ausper Biopharma Co., Ltd.ChinaA Clinical Study of AHB-121 in Healthy Participants and Chronic Hepatitis B (CHB) ParticipantsPhase 1Not Yet Recruiting21 Oct 2026Innovent Biologics (Suzhou) Co. Ltd.ChinaIBI3034 Study in Healthy Adults and Patients With Primary IgA NephropathyPhase 1Not Yet Recruiting21 Oct 2026Jiangsu Hansoh Pharmaceutical Co., Ltd.ChinaA Study of HS-10382 Versus Investigator-selected TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CPPhase 3Not Yet Recruiting21 Oct 2026Lee's Pharmaceutical LimitedChinaStudy to Evaluate the Safety, Tolerability, and Pharmacokinetics of Recombinant Anfibatide Injection in Healthy VolunteersPhase 1Not Yet Recruiting20 Oct 2026a2 Milk Company Ltd.ChinaMilk Free From A1-Type β-Casein With Human Milk Oligosaccharides on Gut Health, Immunity, Cognitive Development, and Temperament in ToddlersNot applicableNot Yet Recruiting20 Oct 2026ChinaNormChinaEffects of a 12-Week Solid Beverage Intervention on Suboptimal Health StatusNot applicableRecruiting20 Oct 2026CSPC Ouyi Pharmaceutical Co., Ltd.ChinaPhase 2 Study of SYH2066 Tablets Compared With Placebo in Chinese Adult Patients With Respiratory Syncytial Virus Infection.Phase 2Not Yet Recruiting20 Oct 2026Shenzhen Salubris Pharmaceuticals Co., Ltd.ChinaThe First-in-Human Study of GW906 InjectionPhase 1Completed20 Oct 2026Waterstone Pharmaceutical (Wuhan) Co., LTD.ChinaA Phase 3 Study Evaluating the Efficacy and Safety of WS016 for the Treatment of HyperkalemiaPhase 3Recruiting// How AOS uses this